Retired 15 years. Basic strategy is to emulate Warren Buffett. Invest or trade in sector leaders to own at lower prices by selling put options below and much below the strike price. When the stock drops below the strike price I buy the stock at the adjusted price, below the market when I initiated the put trade, and even lower reduced by the premium received. Most often though the stock trades above the strike price and I build cash, winning premiums. To reduce risk sell puts at much lower strike prices. SPY puts are favorite trades because very high volumes and low spreads provide better pricing execution, liquidity, and available time choices.
Brandy Betz is a data journalist who has turned an analytical eye towards the stock market for most of her adult life. She spent nearly three years as a writer for The Motley Fool, preceded by a stint at InvestorPlace, and has guest posted at NerdWallet.
Her work has earned citations or sidebar links from a variety of publications including The Washington Post, The Guardian, and The Columbus Dispatch. In addition, her Fool articles were syndicated to several sites including Yahoo, CNN, and DailyFinance.
Industry focuses include healthcare, retail, tech, and long-hold ETFs.
Highly educated private investor with 35 years experience investing in individual stocks and an occasional ETF. I particularly like disruptive technology and growth stocks that are undervalued or beaten down.
Quad 7 Capital, parent company of Quad 7 Partners and Quad 7 Research, was founded in 2017 by long time investor and Seeking Alpha author Dr. Christopher F. Davis. The company has expertise in policy, economics and the sciences. The company has experience with government, academia, and private industry. Quad 7 covers a wide range of sectors and companies, with particular emphasis on growth companies, REITS, biotechnology/ pharmaceuticals, precious metals, blue chips and small-cap companies.
Quad 7 focuses on current events, earnings, and timely developments. Quad 7 aims to conduct 2-3 analyses per business day in addition to working with clientele, personal portfolio advisement and conduct freelance research
After 20 successful years in the IT industry, Richard Saintvilus decided his second act would be as a stock analyst - bringing logic from an investor's point of view. His goal is to remove the complicated aspect of investing and present it to readers in a way that makes sense. Richard's work has been featured on CNBC, Yahoo! Finance, MSN Money, Forbes, Motley Fool and numerous other outlets.
I am an analyst and 2017 Level III Candidate in the CFA Program that has gained experience in the investment industry through positions as a proprietary trader and a portfolio management administrator. I began contributing to Seeking Alpha as a way to share my thoughts on the biopharmaceutical industry. I discussed ways to minimize risk in biopharmaceutical investing through conservative pipeline valuation and balance sheet analysis to identify companies presenting a compelling valuation to potential investors. I also touched on ways to apply knowledge of the markets to improve personal finance. My pieces included either stock-specific analysis or general biopharmaceutical investing discussion through my Biotech Weekly blog. My research appeared on the websites of CNBC, Seeking Alpha, Reuters, Google Finance, Morningstar, NASDAQ, and MarketWatch.
Note: Articles and comments are my own opinions, are not related to the opinions of my employer, and should not be considered investment advice. Make sure to do your own due diligence before making an investment decision. Thanks!
Scott Nursten - Founder / CEO at STRIDE Value Investing
I am a CEO/MD with broad experience in all aspects of running a company. Having worked my way up through the ranks over the past 18 years, I have worked in every role - from front-line support, through middle management and up to the executive level. A strong background in business, financial analysis and technology has enabled me to become involved in 4 rapidly growing businesses.
Experience and Credentials:
Chief Operations Officer at Greenlight Limited since June 2011.
Managing Director at Rescue Consulting since November 2010.
Founder and the Chief Executive Officer at Stride Ltd since September 2008
Served as Managing Director at s2s Limited from January 2008 to August 2010.
Owner and Chief Executive Officer at s2s Limited from March 2000 to December 2007.
Managing Director and Director of Cisco Systems, Inc.'s Gold Partner s2s Ltd.
Founded and served as Chief Executive Officer of s2s Limited.
Served as Technical Director at Data Control & Systems from June 1995 to December 1999.
Non Executive Director at Struto since January 2011.
Serves as a Director of S2S Limited.
Mohit Manghnani is presently a full time editor at Seeking Alpha. He covers the new IPO's and follows live market commentary. Before joining Seeking Alpha, Mohit worked with a start-up - Research firm where he worked in the capacity of a Team Leader tracking company events and results.
Born in the U.A.E, Mohit spent most of his growing up years in Dubai. Currently, he resides in Mumbai, India and is pursuing his charter in Accountancy.
MD and PhD degrees with honors from a top-10 US medical school, followed by residency in internal medicine, international post-doctoral work, and subspecialty training in liver and digestive diseases. Double board-certified former faculty member with extensive research, consulting and speaking experience. 20 years of highly successful investing in biotechnology issues.
Founder, CEO and managing director of Vailshire Capital Management, LLC, in Colorado Springs. Managing director of Vailshire Partners, LP: a healthcare and technology-focused low fee hedge fund. Transitioned in 2015 from full- to part-time medicine as a Diagnostic and Interventional Radiologist in Colorado Springs, CO. Currently a full-time investment professional, managing the flagship hedge fund and separately-managed accounts via Vailshire Capital Management. For inquiries, please use my personal email: email@example.com
My name is Dr Kanak Kanti De, MBBS, MD, PhD, retired medical practitioner, cancer survivor, healthcare sector investor, over 30 years' experience in the sector both in India and the United States. I write/have written on Motley Fool, SeekingAlpha, Benzinga, and on Forbes. I am consistently ranked high on TipRanks, although I don't like their ranking system. My portfolio has consistently beat the various indices for years. Email me to discuss my articles, or for just an adda (Bengali for informal chat) firstname.lastname@example.org.
At Valuentum, we think the best opportunities arise from a complete understanding of all investing disciplines in order to identify the most attractive stocks at any given time. Valuentum therefore analyzes each stock across a wide spectrum of philosophies, from deep value through momentum investing. We think companies that are attractive from a number of investment perspectives--whether it be growth, value, momentum, etc.--have the greatest probability of capital appreciation and relative outperformance. The more investors that are interested in the stock for reasons based on their respective investment mandates, the more likely it will move higher.
Please read our Disclaimer that applies to all articles published on Seeking Alpha: http://www.valuentum.com/categories/20110613
Follow us on Twitter: @Valuentum
We try to provide unbiased, balanced and helpful insight into long-term prospects of the businesses we follow. We mainly base our analysis on the fundamentals and assess the long-term growth potential of the companies. In addition, we also analyze the dividend stability of different companies, and try to assess the future cash flows in order to gauge dividend growth potential.
You can also follow us on twitter here:https://twitter.com/IAEResearch
Earned a Doctorate in Pharmacy (Pharm.D.) in 2010 and Pre-Pharmacy/B.S. in Molecular Biology in 2006. Over six years of direct experience in translational research in oncology investigating the molecular/cellular mechanisms of carcinogenesis focused on biomarker identification and validation working in a multi-disciplinary matrix environment across academia, contract research organizations and industry.
Analyst Tip Ranks: https://www.tipranks.com/experts/dr.-paul-nunzio-desantis%252C-pharm.d
The Life Sciences Report features leading investment coverage of the life sciences sector, including biotechnology, pharmaceuticals, tools & diagnostics, and medical devices. A Streetwise Reports publication. www.TheLifeSciencesReport.com
Over 35 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action; and biotech. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
Editor for The Biotech Forum (www.biotechforumsa.com), the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade. For Free weekly investment reports on small, attractive biotech stocks just register at www.bretjenseninvests.com
I am a market enthusiast and part-time trader. I started writing for Seeking Alpha in 2011, and it has been a tremendous opportunity and learning experience. I have been interested in the markets since elementary school, and hope to pursue a career in the investment management industry. I have been active in the markets for several years, and am primarily focused on long/short equities.
I hold a Bachelor of Science Degree from Lehigh University, where I double majored in Finance and Accounting, with a minor in History. My major track focused on Investments and Financial Analysis. While at Lehigh, I was the Head Portfolio Manager of the Investment Management Group, a student group that manages three portfolios, one long/short and two long only. I have had two internships, one a summer internship at a large bank, and another helping to manage the Lehigh University Endowment for nearly a year.
Disclaimer: Bill reminds investors to always due their own due diligence on any investment, and to consult their own financial adviser or representative when necessary. Any material provided is intended as general information only, and should not be considered or relied upon as a formal investment recommendation.
Craig Van Pelt is a full-time trader specializing in one day, overnight trades of stocks, equity options, index options and ETF's. All trades are opened at the close or in the "After Hours Session," and they're closed-out in the first hour of trading the following day. His trading strategy is based upon his proprietary software program that he developed over some 20 years. The program uses the OEX and its current month OEX Options as the exclusive data input, and predicts the next days "opening" of the market with 80%+ accuracy. Craig is a former stock broker, Registered Investment Advisor & Money Manager. Born in New Jersey, he lived abroad for many years in the Caribbean, Europe and Russia. Craig is 65 years old and now resides in Florida. Villanova University 1965-1969 Honor Student, School of Commerce & Finance.
Saibus Research is an independent research firm that specializes in fundamental deep value research in public securities for fund managers and institutional investors. We don't sell reports, we sell expertise.
For real-time updates: @saibusresearch
Our small-cap hedge fund strategy beat the market by 44 percentage points since its inception 18 months ago. Visit our website to learn how you can do the same. Insider Monkey is a finance website that provides free hedge fund and insider trading data. We believe ordinary investors can beat the market by imitating insiders and best hedge fund managers. They have access to better information and experts than ordinary investors do. Take advantage of the SEC filings where hedge funds and insiders disclose their stock transactions.
Here is our team:
Ms. Krishnamsetty is the Editor of Insider Monkey. Prior to creating Insider Monkey with Dr. Dogan, Ms. Krishnamsetty was Associate Producer at Bloomberg Television. Prior to that, Ms. Krishnamsetty was on the afternoon news team at CNBC. Additionally, Ms. Krishnamsetty reported for NPR and worked as a risk management consultant at Marsh & McLennan. Ms. Krishnamsetty has a M.S. in Journalism from Columbia University’s Graduate School of Journalism.
Insider Monkey’s hybrid evaluation system ...More was created in 2003 by Dr. Ian Dogan. Dr. Dogan has a Ph.D. in financial economics with a specialization in insider trading. Dr. Dogan has provided consulting services to institutional investors and hedge funds, and managed a $200+ million fund using a strategy he developed utilizing insider transactions. Dr. Dogan recently authored the insider trading chapter of soon to be published “The Handbook of Investment Anomalies” by Zacks Investment Research. Insider Monkey will serve the outcome of the methodologies developed by Dr. Dogan to ordinary investors who don’t have access to academic quality research and tools to shape their investments.
For your inquiries please contact us at email@example.com
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Interactive Brokers' Traders Insight is a free online blog drawing together financial market commentary from an array of industry contributors. Exchanges, mutual funds, investment companies and IB analysts provide coverage across stocks, options, futures, forex and fixed income. Visit: Interactive Brokers Group (https://www.interactivebrokers.com) Contact: firstname.lastname@example.org